Home › Funds › Parkman Healthcare Partners LLC › NVCT
Parkman Healthcare Partners LLC position in NVCT
NUVECTIS PHARMA INC · Health Care
Parkman Healthcare Partners LLC reported holding 425,351 shares of NVCT (NUVECTIS PHARMA INC) in its Q3 2026 13F filing — a position valued at US$9.0M, representing 0.81% of its reported portfolio and ranking #47 among its reported holdings. Parkman Healthcare Partners LLC first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's NVCT position evolved
Parkman Healthcare Partners LLC first disclosed a stake in NVCT in Q3 2026 at 425,351 shares (US$9.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 425.35K | $8.98M | New |
About NVCT and 13F data
NVCT (NUVECTIS PHARMA INC) is a Health Care company. 64 other funds we track also report a position in NVCT — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$28.5M), Soleus Capital Management, L.P. (US$18.4M), IRIDIAN ASSET MANAGEMENT LLC/CT (US$16.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVCT
- TANG CAPITAL MANAGEMENT LLC 1.55M sh · $28.50M · Q2 2026
- Soleus Capital Management, L.P. 1.00M sh · $18.39M · Q2 2026
- IRIDIAN ASSET MANAGEMENT LLC/CT 793.21K sh · $16.75M · Q3 2026
- BALDWIN WEALTH PARTNERS LLC/MA 382.01K sh · $8.07M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 382.94K sh · $7.04M · Q2 2026
- Avidity Partners Management LP 200.00K sh · $3.68M · Q2 2026
- Occam Crest Management LP 2.80K sh · $3.09M · Q3 2026
- Squadron Capital Management LLC 38.70K sh · $711.69K · Q2 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held NVCT?
Parkman Healthcare Partners LLC has disclosed NVCT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Parkman Healthcare Partners LLC's current position in NVCT?
As of Q3 2026, Parkman Healthcare Partners LLC holds 425.35K shares of NVCT (NUVECTIS PHARMA INC), valued at $8.98M, representing 0.81% of its reported portfolio and ranking #47.
Has Parkman Healthcare Partners LLC been buying or selling NVCT?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC newly opened its position in NVCT.
Which other funds hold NVCT?
Other major institutional holders of NVCT include TANG CAPITAL MANAGEMENT LLC, Soleus Capital Management, L.P., IRIDIAN ASSET MANAGEMENT LLC/CT, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.